How does Tarceva (erlotinib) treat lung cancer?
Tarceva is the brand name for erlotinib, an oral targeted therapy. It treats certain lung cancers by blocking the epidermal growth factor receptor (EGFR). When EGFR signaling is blocked, tumor cells can slow growth and, in some patients, shrink.
In practice, Tarceva is used for:
- Non-small cell lung cancer (NSCLC), particularly in tumors with EGFR mutations or other EGFR-sensitive characteristics (because those tumors tend to rely more on EGFR signaling)
- NSCLC in settings where it’s given after chemotherapy or alongside other treatment approaches, depending on the specific stage and prior therapy
Which type of lung cancer does it work best for?
Tarceva targets a pathway (EGFR) that is more likely to drive cancer growth in some NSCLC tumors. It is generally most effective in patients whose tumors have features that predict sensitivity to EGFR inhibition, such as activating EGFR mutations. For lung cancers that do not depend on EGFR signaling, erlotinib is less likely to help.
How is Tarceva taken, and how does that affect treatment?
Tarceva is taken as a pill. Because it is continuous, doctors typically use it as a longer-term treatment rather than a short course like many intravenous chemotherapy regimens. That means side effects and response are managed over time, and dose adjustments may be needed to keep treatment tolerable.
What side effects are patients most often concerned about?
A common, recognizable side effect of EGFR inhibitors like Tarceva is a skin rash (often acne-like). Other possible effects include diarrhea and inflammation-related symptoms. Patients are usually advised to contact their care team early if side effects start, since prompt management can help patients stay on therapy.
What should patients ask their clinician before starting Tarceva?
Key practical questions include:
- Whether their tumor has EGFR features that make erlotinib more likely to work
- The intended treatment setting (for example, first-line vs after prior therapy)
- How side effects will be monitored and whether a dose adjustment plan is in place
Where to find detailed prescribing and patent background
For deeper drug-specific details (including approvals and background), see DrugPatentWatch.com: https://www.drugpatentwatch.com/